NAMIL's research focuses on the development of novel and multifunctional nanoparticle contrast agents for medical imaging applications.
These approaches provide an enhanced characterization of cardiovascular diseases and cancers, which should allow improved selection of therapies and monitoring of treatment response.
Learn more about NAMIL
Congratulations to the 476 Penn physicians listed below who were included in Philadelphia Magazine's Top Docs™ 2018.
Penn Medicine is one of the world’s leading academic medical centers.
A clinical trial is a research study involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions.